Tue, Mar 3, 2015, 3:05 AM EST - U.S. Markets open in 6 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Zynga, Inc. Message Board

marginmn 1 post  |  Last Activity: Dec 19, 2014 9:22 AM Member since: Jul 14, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • JUNO IPO's today - expected to be huge. JUNO also is an Immunotherapy play working in the CAR-Tcell space. With today's release SRNE is now also a CAR-Tcell player.

    NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, and Conkwest, Inc., a privately-held immuno-oncology company developing proprietary Neukoplast® (NK-92™), a Natural Killer (NK) cell-line based therapy, announced today that the companies have entered into a definitive agreement to jointly develop next generation CAR-TNK™ (pronounced as "Car-Tank")
    Adoptive immunotherapy is widely regarded as one of the most impactful and innovative anti-cancer therapy breakthroughs. To date, T-cell based therapies, like CAR-T, have shown the most promise in select hematologic cancers,

2.32+0.02(+0.87%)Mar 2 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NXP Semiconductors NV
NASDAQMon, Mar 2, 2015 4:00 PM EST
Palo Alto Networks, Inc.
NYSEMon, Mar 2, 2015 4:02 PM EST